NCT00319137View on ClinicalTrials.gov

An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

December 31, 2005

Conditions
Migraine DisordersMigraine
Interventions
DRUG

GW274150

Trial Locations (5)

1311

GSK Investigational Site, Auckland

2001

GSK Investigational Site, Hamilton

5000

GSK Investigational Site, Adelaide

6035

GSK Investigational Site, Wellington

8001

GSK Investigational Site, Christchurch

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY